Raymond James Financial Inc Relay Therapeutics, Inc. Transaction History
Raymond James Financial Inc
- $258 Billion
- Q1 2025
A detailed history of Raymond James Financial Inc transactions in Relay Therapeutics, Inc. stock. As of the latest transaction made, Raymond James Financial Inc holds 184,533 shares of RLAY stock, worth $669,854. This represents 0.0% of its overall portfolio holdings.
Number of Shares
184,533
Previous 189,046
2.39%
Holding current value
$669,854
Previous $778,000
37.92%
% of portfolio
0.0%
Previous 0.0%
Shares
2 transactions
Others Institutions Holding RLAY
# of Institutions
221Shares Held
164MCall Options Held
153KPut Options Held
49.2K-
Sb Investment Advisers (Uk) LTD London, X027.9MShares$101 Million0.67% of portfolio
-
Vanguard Group Inc Valley Forge, PA12.1MShares$43.9 Million0.0% of portfolio
-
Steven Cohen Point72 Asset Management, L.P. | Stamford, Ct10.8MShares$39.3 Million0.07% of portfolio
-
Black Rock Inc. New York, NY10.5MShares$38.3 Million0.0% of portfolio
-
Casdin Capital, LLC New York, NY9.1MShares$33 Million2.79% of portfolio
About Relay Therapeutics, Inc.
- Ticker RLAY
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 120,219,000
- Market Cap $436M
- Description
- Relay Therapeutics, Inc. operates as a clinical-stage precision medicines company. It engages in transforming the drug discovery process with an initial focus on enhancing small molecule therapeutic discovery in targeted oncology and genetic disease indications. The company's lead product candidates include RLY-4008, an oral small molecule inhib...